204 related articles for article (PubMed ID: 32681396)
1. A study of antigen-specific anti-cytomegalovirus antibody reactivity in patients with systemic sclerosis and concomitant anti-Ro52 antibodies.
Gkoutzourelas A; Liaskos C; Simopoulou T; Katsiari C; Efthymiou G; Scheper T; Meyer W; Tsirogianni A; Tsigalou C; Dardiotis E; Daoussis D; Sakkas LI; Bogdanos DP
Rheumatol Int; 2020 Oct; 40(10):1689-1699. PubMed ID: 32681396
[TBL] [Abstract][Full Text] [Related]
2. Anti-Ro60 Seropositivity Determines Anti-Ro52 Epitope Mapping in Patients With Systemic Sclerosis.
Gkoutzourelas A; Liaskos C; Mytilinaiou MG; Simopoulou T; Katsiari C; Tsirogianni A; Daoussis D; Scheper T; Meyer W; Bogdanos DP; Sakkas LI
Front Immunol; 2018; 9():2835. PubMed ID: 30581434
[TBL] [Abstract][Full Text] [Related]
3. Human cytomegalovirus (HCMV) UL44 and UL57 specific antibody responses in anti-HCMV-positive patients with systemic sclerosis.
Marou E; Liaskos C; Simopoulou T; Efthymiou G; Dardiotis E; Katsiari C; Scheper T; Meyer W; Hadjigeorgiou G; Bogdanos DP; Sakkas LI
Clin Rheumatol; 2017 Apr; 36(4):863-869. PubMed ID: 28124759
[TBL] [Abstract][Full Text] [Related]
4. Clinical performance evaluation of a novel rapid response chemiluminescent immunoassay for the detection of autoantibodies to extractable nuclear antigens.
Bentow C; Swart A; Wu J; Seaman A; Manfredi M; Infantino M; Benucci M; Lakos G; Mahler M
Clin Chim Acta; 2013 Sep; 424():141-7. PubMed ID: 23727029
[TBL] [Abstract][Full Text] [Related]
5. Anti-Ro52 antibody is highly prevalent and a marker of better prognosis in patients with ovarian cancer.
Bogdanos DP; Gkoutzourelas A; Papadopoulos V; Liaskos C; Patrikiou E; Tsigalou C; Saratziotis A; Hajiioannou J; Scheper T; Meyer W; Sakkas LI; Papandreou C
Clin Chim Acta; 2021 Oct; 521():199-205. PubMed ID: 34245687
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies to Cytosolic 5'-Nucleotidase 1A in Primary Sjögren's Syndrome and Systemic Lupus Erythematosus.
Rietveld A; van den Hoogen LL; Bizzaro N; Blokland SLM; Dähnrich C; Gottenberg JE; Houen G; Johannsen N; Mandl T; Meyer A; Nielsen CT; Olsson P; van Roon J; Schlumberger W; van Engelen BGM; Saris CGJ; Pruijn GJM
Front Immunol; 2018; 9():1200. PubMed ID: 29922285
[TBL] [Abstract][Full Text] [Related]
7. Clinical and laboratory aspects of Ro/SSA-52 autoantibodies.
Defendenti C; Atzeni F; Spina MF; Grosso S; Cereda A; Guercilena G; Bollani S; Saibeni S; Puttini PS
Autoimmun Rev; 2011 Jan; 10(3):150-4. PubMed ID: 20854935
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic Utility of Separate Anti-Ro60 and Anti-Ro52/TRIM21 Antibody Detection in Autoimmune Diseases.
Robbins A; Hentzien M; Toquet S; Didier K; Servettaz A; Pham BN; Giusti D
Front Immunol; 2019; 10():444. PubMed ID: 30915082
[TBL] [Abstract][Full Text] [Related]
9. Rapid serological detection of autoantibodies associated with Sjögren's syndrome.
Burbelo PD; Ching KH; Issa AT; Loftus CM; Li Y; Satoh M; Reeves WH; Iadarola MJ
J Transl Med; 2009 Sep; 7():83. PubMed ID: 19778440
[TBL] [Abstract][Full Text] [Related]
10. Sensitive and robust luminescent profiling of anti-La and other autoantibodies in Sjogren's syndrome.
Burbelo PD; Leahy HP; Issa AT; Groot S; Baraniuk JN; Nikolov NP; Illei GG; Iadarola MJ
Autoimmunity; 2009 Sep; 42(6):515-24. PubMed ID: 19657778
[TBL] [Abstract][Full Text] [Related]
11. Anti-Ro52 Autoantibody Is Common in Systemic Autoimmune Rheumatic Diseases and Correlating with Worse Outcome when Associated with interstitial lung disease in Systemic Sclerosis and Autoimmune Myositis.
Chan EKL
Clin Rev Allergy Immunol; 2022 Oct; 63(2):178-193. PubMed ID: 35040083
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of autoantibodies against the nuclear high mobility group (HMG) protein SSRP1 in sera from patients with systemic lupus erythematosus, but not other rheumatic diseases.
Santoro P; De Andrea M; Migliaretti G; Trapani C; Landolfo S; Gariglio M
J Rheumatol; 2002 Jan; 29(1):90-3. PubMed ID: 11824977
[TBL] [Abstract][Full Text] [Related]
13. Clinical associations of the positive anti Ro52 without Ro60 autoantibodies: undifferentiated connective tissue diseases.
Murng SHK; Thomas M
J Clin Pathol; 2018 Jan; 71(1):12-19. PubMed ID: 28663326
[TBL] [Abstract][Full Text] [Related]
14. Increased immunoreactivity against human cytomegalovirus UL83 in systemic sclerosis.
Marou E; Liaskos C; Efthymiou G; Dardiotis E; Daponte A; Scheper T; Meyer W; Hadjigeorgiou G; Bogdanos DP; Sakkas LI
Clin Exp Rheumatol; 2017; 35 Suppl 106(4):31-34. PubMed ID: 28240591
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies associated with systemic sclerosis in three autoimmune diseases imprinted by type I interferon gene dysregulation: a comparison across SLE, primary Sjögren's syndrome and systemic sclerosis.
Andraos R; Ahmad A; Eriksson P; Dahlström Ö; Wirestam L; Dahle C; Hesselstrand R; Bengtsson AA; Jönsen A; Andréasson K; Sjöwall C
Lupus Sci Med; 2022 Dec; 9(1):. PubMed ID: 36581379
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosis.
Hudson M; Pope J; Mahler M; Tatibouet S; Steele R; Baron M; ; Fritzler MJ
Arthritis Res Ther; 2012 Mar; 14(2):R50. PubMed ID: 22394602
[TBL] [Abstract][Full Text] [Related]
17. A review of the role and clinical utility of anti-Ro52/TRIM21 in systemic autoimmunity.
Lee AYS
Rheumatol Int; 2017 Aug; 37(8):1323-1333. PubMed ID: 28417151
[TBL] [Abstract][Full Text] [Related]
18. A comprehensive analysis of antigen-specific antibody responses against human cytomegalovirus in patients with systemic sclerosis.
Efthymiou G; Dardiotis E; Liaskos C; Marou E; Scheper T; Meyer W; Daponte A; Daoussis D; Hadjigeorgiou G; Bogdanos DP; Sakkas LI
Clin Immunol; 2019 Oct; 207():87-96. PubMed ID: 31369821
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of usefulness of Polycheck method in the detection autoantibodies in patients with systemic lupus erythematosus, Sjögren's syndrome and systemic sclerosis].
Dryglewskal M; Majdan M; Koszarny A; Grytal A; Grzywnowicz M
Wiad Lek; 2015; 68(3):252-8. PubMed ID: 26753209
[TBL] [Abstract][Full Text] [Related]
20. Increased frequency of class I and II anti-human leukocyte antigen antibodies in systemic lupus erythematosus and scleroderma and associated factors: a comparative study.
Tozkir H; Pamuk ON; Duymaz J; Gurkan H; Yazar M; Sari G; Tanrikulu H; Pamuk GE
Int J Rheum Dis; 2016 Dec; 19(12):1304-1309. PubMed ID: 25292400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
